国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

神威藥業(yè) Shineway  
神威藥業(yè)集團創(chuàng )建于1992年，是以現代中藥為主業(yè)的大型綜合性企業(yè)集團，綜合競爭力在醫藥行業(yè)居前二十強，在中藥行業(yè)列前五強，是香港聯(lián)合交易所市值最大的中藥企業(yè)，先后榮獲福布斯亞洲200最佳企業(yè)、中國最具成長(cháng)性企業(yè)等殊榮，擁有“神威”、“五?！眱蓚€(gè)中國馳名商標，下屬神威藥業(yè)有限公司、河北神威藥業(yè)有限公司、神威藥業(yè)（張家口）有限公司、神威藥業(yè)（四川）有限公司、神威藥業(yè)營(yíng)銷(xiāo)有限公司、神威大藥房連鎖有限公司等多家子公司，銷(xiāo)售網(wǎng)絡(luò )覆蓋全國30多個(gè)省、自治區、直轄市，產(chǎn)品批量出口。
神威主營(yíng)業(yè)務(wù)涵蓋了中藥材種植、中成藥科研、提取、生產(chǎn)、營(yíng)銷(xiāo)等上中下游產(chǎn)業(yè)鏈，擁有全國最大的神威現代中藥產(chǎn)業(yè)園和多個(gè)符合國家GAP規范的中藥材種植基地，在河北石家莊、廊坊、張家口和四川等地建有生產(chǎn)基地，是全國規模最大、技術(shù)水平最高、質(zhì)量控制能力最強的現代中藥注射液、軟膠囊、顆粒劑專(zhuān)業(yè)制造商。
神威主要針對中老年用藥、兒童用藥、抗病毒用藥等高速增長(cháng)的目標市場(chǎng)，專(zhuān)注發(fā)展現代中藥，形成了現代中藥注射液、現代中藥軟膠囊、現代中藥顆粒劑三大特色劑型，擁有多個(gè)超億元現代中藥大品種，神威清開(kāi)靈注射液、神威參麥注射液、神威舒血寧注射液占據了國內同品種70%以上市場(chǎng)份額，五福心腦清軟膠囊占領(lǐng)90%以上市場(chǎng)份額，神威藿香正氣軟膠囊、清開(kāi)靈軟膠囊、小兒清肺化痰顆粒等產(chǎn)品暢銷(xiāo)全國，每天有超過(guò)600萬(wàn)名患者使用神威系列優(yōu)質(zhì)產(chǎn)品。
神威藥業(yè)集團中藥年提取能力、中藥注射液、軟膠囊、顆粒劑年生產(chǎn)能力均為國內第一。綜合運用指紋圖譜、超臨界萃取、超微粉碎等新技術(shù)，中藥動(dòng)態(tài)逆流提取、注射液洗灌封聯(lián)動(dòng)生產(chǎn)線(xiàn)、軟膠囊全自動(dòng)包裝線(xiàn)等領(lǐng)先工藝設備，廣泛應用計算機控制技術(shù)，實(shí)現了中藥生產(chǎn)的標準化、中藥劑型的現代化、質(zhì)量控制的規范化、生產(chǎn)裝備的自動(dòng)化，使神威現代中藥產(chǎn)品達到了“安全、有效、穩定、可控”的現代標準。神威設有國家級企業(yè)技術(shù)中心和院士工作站，建成全國唯一的“中藥制劑先進(jìn)工藝集成及生產(chǎn)過(guò)程自動(dòng)控制高技術(shù)產(chǎn)業(yè)化示范工程”和“中藥注射液質(zhì)量標準化示范工程”等國家高技術(shù)產(chǎn)業(yè)化示范項目，承擔多項科技部課題，成為國家863成果產(chǎn)業(yè)化基地，被國家人事部批準設立博士后科研工作站。
展望未來(lái)，神威藥業(yè)將繼續專(zhuān)注于現代中藥的研發(fā)、生產(chǎn)和銷(xiāo)售，著(zhù)重培養以需求為導向的研發(fā)、以成本和質(zhì)量為要求的精益生產(chǎn)、以傳統渠道為依托以掌控終端為最終目的的營(yíng)銷(xiāo)、以及以嚴細求實(shí)為核心的神威文化等四個(gè)方面的核心競爭力，致力于成為中國最大、盈利能力一流的專(zhuān)業(yè)中藥制造企業(yè)，引領(lǐng)現代中藥，推進(jìn)健康產(chǎn)業(yè)。

China Shineway Pharmaceutical Group is now the largest manufacturer of modern Chinese medicine injections, soft capsules and granules. The Group’s state-of-the-art facilities are located in Shijiazhuang and Lang Fang.

The Group is listed on the Main Board of the Stock Exchange of Hong Kong and is a constituent of the Hang Seng Composite Index ranking among the top 200 public companies on the counter.

Shineway’s brand names and products are widely recognized in the PRC. The Group offers a range of prescription and OTC modern Chinese medicines. Main products include Shen Mai injection, Qing Kai Ling injection and Wu Fu Xin Nao Qing soft capsule – each has sales revenue of over 150 million Renminbi annually. Together with over 45 regularly produced modern Chinese medicines such as Shu Xue Ning injection, Huang Qi injection, Huo Xiang Zheng Qi soft capsule, Qing Kai Ling soft capsule and a series of granule products, Shineway’s modern Chinese medicines are primarily focused on the treatment of illness commonly affecting middle and old aged people and children, including cardiovascular diseases, respiratory system sickness, cold and fever, digestive system diseases, and medicines for anti-viral treatment. All are sold under the “Shineway” brand.

As an officially certified “China Famous Trademark”, Shineway is a well known brand and its products are popular among the Chinese people. Shineway’s prominent brands and products have won numerous honors and awards, including “China Five Hundred Most Valuable Brand”, “State Key New Products” and “China Hi-Tech Products”. A number of Shineway key products are also labeled as “State Protected Chinese medicines” and “Good Quality / Good Price” products.